GB1213571A

GB1213571A – Derivatives of cephalosporanic acid
– Google Patents

GB1213571A – Derivatives of cephalosporanic acid
– Google Patents
Derivatives of cephalosporanic acid

Info

Publication number
GB1213571A

GB1213571A
GB871/68A
GB87168A
GB1213571A
GB 1213571 A
GB1213571 A
GB 1213571A
GB 871/68 A
GB871/68 A
GB 871/68A
GB 87168 A
GB87168 A
GB 87168A
GB 1213571 A
GB1213571 A
GB 1213571A
Authority
GB
United Kingdom
Prior art keywords
formula
compound
compounds
pyridylthio
cephalosporanic acid
Prior art date
1967-01-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Application number
GB871/68A
Inventor
Leonard Bruce Crast Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bristol Myers Co

Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1967-01-05
Filing date
1968-01-05
Publication date
1970-11-25

1968-01-05
Application filed by Bristol Myers Co
filed
Critical
Bristol Myers Co

1970-11-25
Publication of GB1213571A
publication
Critical
patent/GB1213571A/en

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

C07D501/14—Compounds having a nitrogen atom directly attached in position 7

C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3

C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids

C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

C07D501/36—Methylene radicals, substituted by sulfur atoms

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/33—Heterocyclic compounds

A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins

A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems

A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Abstract

1,213,571. Cephalosporins. BRISTOLMYERS CO. 5 Jan., 1968 [5 Jan., 1967], No. 871/68. Heading C2A. The invention comprises an α-pyridylthioacetamido cephalosporanic acid derivative of formula wherein A is H, OH, C 2-8 alkanoyloxy, benzyloxy, a quaternary ammonium radical especially pyridinium, quinolinium, picolinium or lutidinium, or, when taken together with M is a monovalent C-O bond; and M is H, a pharmaceutically acceptable non-toxic cation, an anionic charge when A is a quaternery NH 4 radical or, when taken together with A, is a monovalent C-O bond; and Z is 2,- 3,- or 4- pyridyl. The compounds are prepared by (a) reacting a compound of formula: wherein A and M have the above meaning, with an α-haloacetyl halide of formula in which Hal is chloro, bromo or iodo, or its functional equivalent as an acylating agent, in the presence of a base, to produce an α- haloacetamido compound of formula wherein A and M are as defined above, and (b) reacting the thus-prepared α-haloacetamido compound in the presence of a base with a mercaptan of formula Z-SH wherein Z has the above meaning. Salts are formed with inorganic cations e.g. sodium and potassium, organic amine cations e.g. triethylamine, procaine and N-ethylpiperidine and with inorganic acids e.g. hydrochloric and organic acids e.g. acetic and ascorbic. Typical compounds are 7-[a-(4-pyridylthio)-acetamido]cephalosporanic acid and 3-methyl-7-[α-(4-pyridylthio) acetamido-]-3-cephem-4-carboxylic acid monophosphate. The 3- and 4-pyridyl compounds are more active against gram-negative bacteria than the 2-pyridyl compound. A pharmaceutical composition for parenteral or oral administration to man and animals comprises an α-pyridylthio acetamido cephalosporanic acid of Formula I and a carrier. The compositions may be used for treating mastitis in cattle. The compounds may be used as nutritional supplements in animal feeds.

GB871/68A
1967-01-05
1968-01-05
Derivatives of cephalosporanic acid

Expired

GB1213571A
(en)

Applications Claiming Priority (1)

Application Number
Priority Date
Filing Date
Title

US60737867A

1967-01-05
1967-01-05

Publications (1)

Publication Number
Publication Date

GB1213571A
true

GB1213571A
(en)

1970-11-25

Family
ID=24432009
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

GB871/68A
Expired

GB1213571A
(en)

1967-01-05
1968-01-05
Derivatives of cephalosporanic acid

Country Status (11)

Country
Link

AT
(1)

AT276626B
(en)

BE
(1)

BE709019A
(en)

CH
(1)

CH487181A
(en)

DE
(1)

DE1670301C3
(en)

DK
(1)

DK126595B
(en)

FR
(2)

FR1580837A
(en)

GB
(1)

GB1213571A
(en)

IL
(1)

IL29235A
(en)

NL
(1)

NL6800176A
(en)

NO
(1)

NO140269C
(en)

SE
(1)

SE349564B
(en)

Cited By (2)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

GB2122603A
(en)

*

1982-06-25
1984-01-18
Lark Spa
7-Ä???-(substituted-thio)-acylamidoÜ-cephalosporanic acids

EP0953570A1
(en)

*

1998-04-30
1999-11-03
Eli Lilly And Company
Fluorinated cephalosporin antibiotics and their use for the treatment of mastitis

Families Citing this family (5)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

BE758764A
(en)

*

1969-11-13
1971-05-10
Bristol Myers Co

PROCESS FOR PREPARING ANTIBACTERIAL AGENTS

US3631027A
(en)

*

1970-03-27
1971-12-28
Bristol Myers Co
Cephalosporanic acids

JPS5854157B2
(en)

*

1977-06-10
1983-12-02
山之内製薬株式会社

New derivatives of cephalosporin compounds and their production method

DE2824559C2
(en)

1977-06-10
1985-01-10
Yamanouchi Pharmaceutical Co., Ltd., Tokio / Tokyo

7α-methoxy-7β- (4-substituted-methylen-1,3-dithietan-2-yl) -carboxamido-3-Δ 3 -cephem-4-carboxylic acids, processes for their preparation and their use

IT1141406B
(en)

*

1980-04-01
1986-10-01
Dob Far Spa

SALTS OF CEPHAPIRINE WITH AMINO ACIDS

1967

1967-12-28
IL
IL2923567A
patent/IL29235A/en
unknown

1968

1968-01-03
DE
DE19681670301
patent/DE1670301C3/en
not_active
Expired

1968-01-03
DK
DK1368A
patent/DK126595B/en
not_active
IP Right Cessation

1968-01-04
NO
NO3568A
patent/NO140269C/en
unknown

1968-01-05
GB
GB871/68A
patent/GB1213571A/en
not_active
Expired

1968-01-05
CH
CH15068A
patent/CH487181A/en
not_active
IP Right Cessation

1968-01-05
SE
SE14068A
patent/SE349564B/xx
unknown

1968-01-05
AT
AT13268A
patent/AT276626B/en
active

1968-01-05
FR
FR1580837D
patent/FR1580837A/fr
not_active
Expired

1968-01-05
BE
BE709019D
patent/BE709019A/xx
not_active
IP Right Cessation

1968-01-05
NL
NL6800176A
patent/NL6800176A/xx
unknown

1968-02-02
FR
FR138533A
patent/FR8381M/fr
not_active
Expired

Cited By (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

GB2122603A
(en)

*

1982-06-25
1984-01-18
Lark Spa
7-Ä???-(substituted-thio)-acylamidoÜ-cephalosporanic acids

EP0953570A1
(en)

*

1998-04-30
1999-11-03
Eli Lilly And Company
Fluorinated cephalosporin antibiotics and their use for the treatment of mastitis

US6369049B1
(en)

1998-04-30
2002-04-09
Eli Lilly And Company
Treatment of mastitis

Also Published As

Publication number
Publication date

NO140269C
(en)

1979-08-01

SE349564B
(en)

1972-10-02

NO140269B
(en)

1979-04-23

DK126595B
(en)

1973-07-30

AT276626B
(en)

1969-11-25

BE709019A
(en)

1968-07-05

CH487181A
(en)

1970-03-15

DE1670301A1
(en)

1972-02-24

DE1670301B2
(en)

1975-05-07

DE1670301C3
(en)

1975-12-18

IL29235A
(en)

1971-10-20

FR1580837A
(en)

1969-09-12

FR8381M
(en)

1971-03-01

NL6800176A
(en)

1968-07-08

Similar Documents

Publication
Publication Date
Title

ES367294A1
(en)

1971-04-01

3,7-disubstituted cephalosporin compounds and preparation thereof

GB1213571A
(en)

1970-11-25

Derivatives of cephalosporanic acid

GB1377762A
(en)

1974-12-18

8-oxo-5-thia-1-azabicyclo-4,2,0 oct- 2-ene-compounds process for their manufacture and compositions containing them

ES427079A1
(en)

1976-07-16

Phenothiazine derivatives, compositions thereof and methods of preparation thereof

GB1289358A
(en)

1972-09-20

GB1322482A
(en)

1973-07-04

Glutamic acid derivatives their preparation and compositions containing the same

GB1429539A
(en)

1976-03-24

Derivatives of penam-3-carboxylic acid and cephem-4-carboxylic acid and processes for their manufacture

GB1432714A
(en)

1976-04-22

7- alpha-halomethyl-arly- acetamide- cephalosporin derivatives

GB1138768A
(en)

1969-01-01

Cephalosporanic acid derivatives

GB1247711A
(en)

1971-09-29

Antibacterial agents and a process for the preparation thereof

GB1318478A
(en)

1973-05-31

Cephalexin salts

GB1291878A
(en)

1972-10-04

Cephalosporanic acid derivatives

DE3419013A1
(en)

1985-11-28

NEW CEPHALOSPORINE AND METHOD FOR THEIR PRODUCTION

GB1162247A
(en)

1969-08-20

Cephalosporanic Acid Derivatives and a Process for the Preparation thereof

GB1284227A
(en)

1972-08-02

Penicillin and cephalosporin derivatives

GB1411700A
(en)

1975-10-29

Penicillins and production thereof

GB1131645A
(en)

1968-10-23

Cephalosporins

GB1137113A
(en)

1968-12-18

Cephalosporanic acid derivatives

GB1028563A
(en)

1966-05-04

Antibacterial derivative of 7-aminocephalosporanic acid

GB1392241A
(en)

1975-04-30

Antibacterial agents and a process for the preparation thereof

GB1252248A
(en)

1971-11-03

GB1288967A
(en)

1972-09-13

GB1134682A
(en)

1968-11-27

Improvements in or relating to derivatives of 6-aminopenicillanic acid

GB1124920A
(en)

1968-08-21

Penicillins and a process for the preparation thereof

GB1298088A
(en)

1972-11-29

Penicillanic acids

Legal Events

Date
Code
Title
Description

1971-05-19
PS
Patent sealed

1988-02-10
PE20
Patent expired after termination of 20 years

Download PDF in English

None